Dacula, Habiba C.
HRN: 22-25-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/29/2022
12/06/2022
IV
4.5g
Q6h
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes